5 results
10-K
2019 FY
BBIO
BridgeBio Pharma Inc
3 Mar 20
Annual report
6:07am
with these requirements could result in reputational risk, public reprimands, administrative penalties, fines or imprisonment.
European Union Drug Review
DRS/A
BBIO
BridgeBio Pharma Inc
16 Apr 19
Draft registration statement (amended)
12:00am
States. Failure to comply with these requirements could result in reputational risk, public reprimands, administrative penalties, fines
- Prev
- 1
- Next